Rare disease impacts many. And we have the scientific tools to make real solutions. Time to crack these challenges to go from hopeless to hope to help to cures.
Hello BlueSky. One of our cofounders, Linde Jacobs, is profiled in The New York Times today. It’s a moving snapshot of what an FTD family goes through. Help us fight for therapies that can cure dementia for under 60s. #ftd #aftd #dementia #tau #alzheimers #mapt
www.nytimes.com/2024/12/22/h...
Comments